6-108561360-C-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001455.4(FOXO3):c.152C>T(p.Thr51Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000262 in 1,563,620 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T51A) has been classified as Uncertain significance.
Frequency
Consequence
NM_001455.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000988 AC: 15AN: 151790Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000553 AC: 8AN: 144580 AF XY: 0.0000758 show subpopulations
GnomAD4 exome AF: 0.0000170 AC: 24AN: 1411718Hom.: 0 Cov.: 31 AF XY: 0.0000100 AC XY: 7AN XY: 698098 show subpopulations
GnomAD4 genome AF: 0.000112 AC: 17AN: 151902Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74254 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.152C>T (p.T51M) alteration is located in exon 1 (coding exon 1) of the FOXO3 gene. This alteration results from a C to T substitution at nucleotide position 152, causing the threonine (T) at amino acid position 51 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at